http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114425443-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd51255ea83c3ba9646b5d68cf649334
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2231-70
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-0248
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-0222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J35-0006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-0244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J27-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
filingDate 2021-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_284ae79aafd6c2bd13f5e10d99f586c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d884ff4069f0f17e52335c9994b352b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e915dc5c30ef671755d7d4a580a7ba23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43bdeb85ea534c512ba7bfb73751ff2d
publicationDate 2022-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114425443-A
titleOfInvention An oligonucleotide synthesis catalyst
abstract The present invention provides an oligonucleotide synthesis catalyst and a preparation method thereof, and a method for synthesizing an oligonucleotide, wherein the oligonucleotide synthesis catalyst comprises tetrazoles, azole salts and pyridinium salts as main components At least one of the compounds of the class of compounds and imidazolium salts, and polar additives. The oligonucleotide synthesis catalyst of the present invention solves the problem of the current oligonucleotide synthesis process for complex (for example, the oligonucleotide chain length is too long, the GC content is high, and the repeat or continuous sequence is easy to produce secondary structures) The nucleotide sequence synthesis is difficult, and it is difficult to obtain the target oligonucleotide fragment or the target oligonucleotide fragment has many impurities and poor quality. When the oligonucleotide synthesis catalyst of the present invention is applied to oligonucleotide synthesis, the success rate of oligonucleotide synthesis with high GC content can be increased, and the quality of the oligonucleotide can be improved.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114685572-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114685572-B
priorityDate 2020-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415726514
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3937002
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426004529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571897
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451271143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2724541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3811882
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135478149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410408351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449433785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410135424
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID47346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24785025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID433294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421462122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID309472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450422860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10080320
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4989215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426009906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410443642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1390

Total number of triples: 61.